MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 1 filers reported holding MIRATI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,077 | +1167.1% | 24,720 | +1224.8% | 0.47% | +715.5% |
| Q4 2022 | $85 | -100.0% | 1,866 | -48.3% | 0.06% | -78.3% |
| Q1 2022 | $296,000 | +218.3% | 3,612 | +542.7% | 0.27% | +184.0% |
| Q3 2020 | $93,000 | -89.4% | 562 | -93.4% | 0.09% | -71.8% |
| Q2 2020 | $881,000 | 0.0% | 8,554 | 0.0% | 0.33% | -33.0% |
| Q2 2019 | $881,000 | – | 8,554 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |